Sunday, September 25, 2022
wellness India Expo
Home Tags Oncology

Tag: Oncology

MGM Healthcare launches dedicated Cancer Centre in Chennai

The state-of-the-art facility is said to be designed to be a holistic destination for cancer treatment

DCGI approves AstraZeneca’s Lynparza as a monotherapy for high-risk early breast...

Lynparza is the first and only approved PARPi targeting BRCA-mutated HER2-negative high-risk early breast cancer

Programmed death in cancer cells: Overcoming resistance through paraptosis-inducing compounds

Researchers from Japan have developed novel complex-peptide hybrids, which can induce programmed cell death in apoptosis-resistant cancer cells 

Genes2Me launches NGS based panels for key diseases

For the first time in India, Genes2Me launches a range of path breaking and revolutionary NGS based clinical panels

CCI approves merger by absorption of Covidshield Technologies into Biocon Biologics

The target is a subsidiary of Biocon Limited, and it offers treatment for chronic and acute diseases such as diabetes, oncology, nephrology, cancer, and autoimmune diseases

Cadila Pharma expands its oncology portfolio with monoclonal antibody, Tarzed

TARZED is considered safe and more efficacious compared to conventional treatment medicines for breast cancer

GHA & 8chili Inc. launch healthcare training & education platform in...

The collaboration has already published 200+ hours of virtual reality (VR) content across multiple subspecialties including Dentistry, Oral and Maxillofacial surgery, Orthopedics, Skull base, Spine, Neurology, ENT, Paramedics, Nursing, and Oncology

Leading oncologists call for greater adoption of tech innovations to improve...

At the event organized by Oncology Forum and Fortis Cancer Institute, Delhi NCR, global experts also emphasized on the need for collaborative efforts to bring globally acclaimed treatment solutions for patients suffering from cancer

CORE Diagnostics gets accredited by College of American Pathologists

Accreditation by CAP is widely regarded internationally in the diagnostics industry that signifies the highest quality standards of tests across regions...........................

Lupin achieves key milestones for its potential therapy to treat difficult...

Lupin’s proprietary MEK inhibitor compound is planned for clinical development in combination with Boehringer Ingelheim’s KRAS inhibitor pipeline to address KRAS-driven cancer...........................